Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply. JAMA Intern Med. 2013 Mar 25; 173(6):476-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.